Sage Therapeutics Inc. sell Citigroup Inc.
Start price
29.05.24
/
50%
€10.05
Target price
29.05.25
€7.37
Performance (%)
-37.45%
Price
01.10.24
€6.29
Summary
This prediction is currently active. Massive losses of -37.45% have been the result for the SELL prediction by Citigroup_Inc_. This prediction currently runs until 29.05.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sage Therapeutics Inc. | -3.972% | -3.972% |
| iShares Core DAX® | 1.164% | 1.549% |
| iShares Nasdaq 100 | 0.118% | 0.969% |
| iShares Nikkei 225® | 1.124% | -1.120% |
| iShares S&P 500 | 0.479% | 1.068% |
Comments by Citigroup_Inc_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) is now covered by analysts at Citigroup Inc.. They set a "sell" rating and a $8.00 price target on the stock.
Ratings data for SAGE provided by MarketBeat